1. Home
  2. Labeler Index
  3. Leo Pharma Inc.
  4. 50222-302
  5. NDC Package Code: 50222-302-60 Enstilar

NDC Package 50222-302-60 Enstilar

Calcipotriene And Betamethasone Dipropionate Aerosol, Foam Topical - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
50222-302-60
Package Description:
1 CAN in 1 CARTON / 60 g in 1 CAN
Product Code:
50222-302
Proprietary Name:
Enstilar
Non-Proprietary Name:
Calcipotriene And Betamethasone Dipropionate
Substance Name:
Betamethasone Dipropionate; Calcipotriene Monohydrate
Usage Information:
This medication is used to treat psoriasis. It helps to reduce the redness, thickening, and scaling of the skin that occurs with this condition. Healthy skin lowers your risk for infection and protects you against the environment. This product contains 2 drugs. Betamethasone is a very strong corticosteroid drug that works by decreasing swelling, redness, and itching. Calcipotriene is a form of vitamin D. It is also known as calcipotriol in other countries. It works by slowing down the growth of skin cells so that they don't build up into thickened, scaly skin patches. This product should not be used if you have certain types of psoriasis (skin patches with pus-filled blisters, psoriasis over most of your body with intense redness/shedding/oozing). Consult your doctor for more information.
11-Digit NDC Billing Format:
50222030260
Billing Unit:
GM - Billing unit of "gram" is used when a product is measured by its weight.
NDC to RxNorm Crosswalk:
60 GM
NDC to RxNorm Crosswalk:
  • RxCUI: 1716094 - calcipotriene 0.005 % / betamethasone propionate 0.064 % Topical Foam
  • RxCUI: 1716094 - betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Foam
  • RxCUI: 1716099 - Enstilar 0.005 % / 0.064 % Topical Foam
  • RxCUI: 1716099 - betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Foam [Enstilar]
  • RxCUI: 1716099 - Enstilar (calcipotriene 0.005 % / betamethasone dipropionate 0.064 % ) Topical Foam
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Leo Pharma Inc.
    Dosage Form:
    Aerosol, Foam - A dosage form containing one or more active ingredients, surfactants, aqueous or nonaqueous liquids, and the propellants; if the propellant is in the internal (discontinuous) phase (i.e., of the oil-in-water type), a stable foam is discharged, and if the propellant is in the external (continuous) phase (i.e., of the water-in-oil type), a spray or a quick-breaking foam is discharged.
    Administration Route(s):
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
    • Active Ingredient(s):
  • BETAMETHASONE DIPROPIONATE .5 mg/g
  • CALCIPOTRIENE MONOHYDRATE 50 ug/g
    • Pharmacologic Class(es):
  • Corticosteroid Hormone Receptor Agonists - [MoA] (Mechanism of Action)
  • Corticosteroid - [EPC] (Established Pharmacologic Class)
  • Vitamin D Analog - [EPC] (Established Pharmacologic Class)
  • Vitamin D - [CS]
    • Sample Package:
    No
    FDA Application Number:
    NDA207589
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    10-16-2015
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    50222-302-662 CAN in 1 CARTON / 60 g in 1 CAN
    50222-302-911 CAN in 1 CARTON / 60 g in 1 CAN

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 50222-302-60?

    The NDC Packaged Code 50222-302-60 is assigned to a package of 1 can in 1 carton / 60 g in 1 can of Enstilar, a human prescription drug labeled by Leo Pharma Inc.. The product's dosage form is aerosol, foam and is administered via topical form.

    Is NDC 50222-302 included in the NDC Directory?

    Yes, Enstilar with product code 50222-302 is active and included in the NDC Directory. The product was first marketed by Leo Pharma Inc. on October 16, 2015 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 50222-302-60?

    The contents of this package are billed per "gm or gram", products billed per gram are products measured by weight. The calculated billable units for this package is 60.

    What is the 11-digit format for NDC 50222-302-60?

    The 11-digit format is 50222030260. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-250222-302-605-4-250222-0302-60